brigatinib (Alunbrig™) Alunbrig™ (brigatinib) Approval Criteria [Non-Small Cell Lung Cancer (NSCLC) Diagnosis]: A diagnosis of metastatic NSCLC; AND Airway hyperreactivity, which is a short-term narrowing of the airways with impairment or limitation of the amount of air flowing into and out of the lungs, is common in acute bronchitis. The supportive therapies (e.g. antiemetics, premedications, etc.), infusion times, diluents, volumes and routes of administration, if included, are listed as defaults. Clarithromycin is a prescription drug used to treat a wide variety of bacterial infections. Learn about side effects, drug interactions, dosages, warnings, and more. Treating bronchiectasis with antibiotics is common because bacteria often infect the bronchi. Your healthcare provider will decide whether you should be treated with antibiotics that you take by mouth or with antibiotics that are given through the veins (intravenously). PREVPAC (lansoprazole 30 mg delayed release capsules, amoxicillin 500 mg capsules, USP, and clarithromycin 500 mg tablets, USP) DESCRIPTION. PREVPAC consists of a daily administration card containing two PREVACID 30 mg delayed release capsules, four amoxicillin 500 mg capsules, USP, and two clarithromycin 500 mg tablets, USP, for oral. 1,000 mg PO once daily for 7 days. Clinical practice guidelines recommend clarithromycin as a monotherapy option in previously healthy outpatients with no risk factors for drug-resistant S. pneumoniae and without therapy in the preceding 3 months. INSIGNA: A Randomized, Phase III Study of Firstline Immunotherapy Alone or in Combination with Chemotherapy in Induction/Maintenance or Postprogression in Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) with Immunobiomarker SIGNature-Driven Analysis Lansoprazole, Amoxicillin and Clarithromycin official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. eviQ Education Learning resources for cancer staff Cancer Institute NSW NSW cancer control agency Patient Information.